Talk:Bioblast 2022: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 200: | Line 200: | ||
|- | |- | ||
|- | |- | ||
| || || 16:45 || [[Eggelbusch 2022 Abstract Bioblast|Nutrient overload and insulin resistance precede reductions in mitochondrial respiration in skeletal muscle after bed rest]] || Eggelbusch | | || || 16:45 || [[Eggelbusch 2022 Abstract Bioblast|Nutrient overload and insulin resistance precede reductions in mitochondrial respiration in skeletal muscle after bed rest]] || [[Eggelbusch Moritz]] | ||
|- | |- | ||
|- | |- | ||
| || || 16:50 || [[Batra 2022 Abstract Bioblast|Nano-encapsulated Dichloroacetophenone (DAP) essential mitochondrial enzyme, is a potential inhibitor of prostate cancer cell growth]]|| Batra Jyotsna | | || || 16:50 || [[Batra 2022 Abstract Bioblast|Nano-encapsulated Dichloroacetophenone (DAP) essential mitochondrial enzyme, is a potential inhibitor of prostate cancer cell growth]]|| [[Batra Jyotsna]] | ||
|- | |- | ||
|- | |- |
Revision as of 17:38, 13 June 2022
Program
2022-06-29 Day 1 of scientific presentations
2022-06-30 Day 2 of scientific presentations